HGH Fragment 176-191
$Fat-metabolism fragment; Human efficacy uncertain
HGH Fragment 176-191 is a short C-terminal portion of the growth hormone molecule promoted for fat metabolism. It is not full growth hormone and should not be treated as the same product as AOD-9604.
Many claims are mechanistic or anecdotal. Human fat-loss efficacy and human PK are not established well enough to support strong protocols. Be cautious with fasting-window rules presented as certainty. Separate lipolysis signals, actual fat oxidation, appetite, adherence, and measured body-composition change.
Classification details
- HGH Fragment 176-191 is a synthetic fragment derived from amino acids 176 to 191 of human growth hormone.
- It is discussed as a metabolic fragment rather than a full GH receptor agonist.
- HGH Fragment 176-191 is the C-terminal hGH fragment conceptually related to AOD-9604, but product naming can be inconsistent. It is not full growth hormone.
- The proposed action involves lipolysis-related signaling without the broader growth-promoting effects of full hGH.
- This proposed selectivity is not the same as proven clinical fat loss.
- The proposed mechanism is lipolysis/fat-metabolism modulation without broad hGH growth signaling. The mechanism is narrower than hGH, but clinical fat-loss effect remains uncertain.